Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients
Lung Cancer, 04/26/2012
Clinical Article
Kuang P et al. – DDH2 expression might be a potential predictor and monitor of cisplatin efficacy in advanced NSCLC patients.



